Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Clinical Immunosuppression Kidney early
15 August 2010  /  00:01 - 00:01

Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

- Evaluation of limited sampling strategies for tacrolimus (Prograf®) exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

Retrospective Analysis of Timing of Basiliximab Induction and Effect on One Year Outcomes Following Kidney Transplantation

Presenter: S Joseph Kim, Toronto, Canada

- Retrospective Analysis of Timing of Basiliximab Induction and Effect on One Year Outcomes Following Kidney Transplantation

Presenter: S Joseph Kim, Toronto, Canada

Pharmacokinetics of Once-Daily Tacrolimus Extended Release (TER) in de novo Renal Transplantation induction immunotherapy.

Presenter: Kazunari Yoshida, Sagamihara, Japan

- Pharmacokinetics of Once-Daily Tacrolimus Extended Release (TER) in de novo Renal Transplantation induction immunotherapy.

Presenter: Kazunari Yoshida, Sagamihara, Japan

Mycophenolate sodium dosing in combination with tacrolimus: Pharmacokinetic evaluation of a novel regimen in de novo kiney transplant patients.

Presenter: Bertrand Pons, SAINT PRIEST EN JAREZ, France

- Mycophenolate sodium dosing in combination with tacrolimus: Pharmacokinetic evaluation of a novel regimen in de novo kiney transplant patients.

Presenter: Bertrand Pons, SAINT PRIEST EN JAREZ, France

The Effect of Immunosuppression on regeneration of the renal tubules

Presenter: Delawir Kahn, Cape Town, South Africa

- The Effect of Immunosuppression on regeneration of the renal tubules

Presenter: Delawir Kahn, Cape Town, South Africa

Pharmacodynamic Evaluation of Cyclosporine in B-cell

Presenter: Takafumi Kuzuya, Nagoya, Japan

- Pharmacodynamic Evaluation of Cyclosporine in B-cell

Presenter: Takafumi Kuzuya, Nagoya, Japan

Steroid Free Immunosuppression in Kidney Transplantation : initial experience in Asian Indian population

Presenter: Sanjeev Gulati, NEW DELHI, India

- Steroid Free Immunosuppression in Kidney Transplantation : initial experience in Asian Indian population

Presenter: Sanjeev Gulati, NEW DELHI, India

PRCA successfully treated with immunosuppression followed by kidney transplantation

Presenter: Wladyslaw Sulowicz, Krakow, Poland

- PRCA successfully treated with immunosuppression followed by kidney transplantation

Presenter: Wladyslaw Sulowicz, Krakow, Poland

Very early CsA reduction synchronizes with de novo everolimus therapy in kidney transplant recipients: a four year follow up with pharmacokinetic study.

Presenter: Vasant Sumethkul, Bangkok, Thailand

- Very early CsA reduction synchronizes with de novo everolimus therapy in kidney transplant recipients: a four year follow up with pharmacokinetic study.

Presenter: Vasant Sumethkul, Bangkok, Thailand

short-term clinical result to use of extended release tacrolimus in kidney transplant recipients

Presenter: Jesus Bustamante Bustamante, Valladolid, Spain

- short-term clinical result to use of extended release tacrolimus in kidney transplant recipients

Presenter: Jesus Bustamante Bustamante, Valladolid, Spain

Clinically Better Renal Function With Everolimus and Very Low Tacrolimus Exposure in De novo Renal Transplant Recipients at 12 Months: The ASSET Study

Presenter: Maarten Christiaans, Maastricht, Netherlands

- Clinically Better Renal Function With Everolimus and Very Low Tacrolimus Exposure in De novo Renal Transplant Recipients at 12 Months: The ASSET Study

Presenter: Maarten Christiaans, Maastricht, Netherlands

Comparable Patient Reported Outcomes with Initially Intensified Dosing versus Standard Dosing of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients

Presenter: Bryce Kiberd, Halifax, Canada

- Comparable Patient Reported Outcomes with Initially Intensified Dosing versus Standard Dosing of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients

Presenter: Bryce Kiberd, Halifax, Canada

Evaluation of the pharmacokinetics of prednisolone and limited sampling strategies for estimation of prednisolone exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

- Evaluation of the pharmacokinetics of prednisolone and limited sampling strategies for estimation of prednisolone exposure in adult kidney transplant recipients

Presenter: Katherine Barraclough, Brisbane, Australia

Everolimus Allows For A 60% Reduction in Cyclosporine Exposure in Subject Cohorts defined by Geography

Presenter: R Walker, Melbourne, Australia

- Everolimus Allows For A 60% Reduction in Cyclosporine Exposure in Subject Cohorts defined by Geography

Presenter: R Walker, Melbourne, Australia

Differential effects of immunosuppressive agents on renal function after ischemia-reperfusion injury: New insights by using 99mTc-MAG3 imaging

Presenter: Tanja Herrler, Munich, Afghanistan

- Differential effects of immunosuppressive agents on renal function after ischemia-reperfusion injury: New insights by using 99mTc-MAG3 imaging

Presenter: Tanja Herrler, Munich, Afghanistan

An Intensified Dosing Of Enteric-Coated Mycophenolate Sodium In Renal Transplant Patients Results In Improved Efficacy Without Compromising Safety: 1 Year Follow-Up Results

Presenter: Wolfgang Arns, Koeln-Merheim, Germany

- An Intensified Dosing Of Enteric-Coated Mycophenolate Sodium In Renal Transplant Patients Results In Improved Efficacy Without Compromising Safety: 1 Year Follow-Up Results

Presenter: Wolfgang Arns, Koeln-Merheim, Germany

Kidney transplantation outcomes of crossmatch positive and ABO-incompatible patients. Single center experience

Presenter: Kumar Gaurav, Charlottesville, United States

- Kidney transplantation outcomes of crossmatch positive and ABO-incompatible patients. Single center experience

Presenter: Kumar Gaurav, Charlottesville, United States

Renal Function of an Everolimus based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients One Year After Conversion

Presenter: Klemens Budde, Berlin, Germany

- Renal Function of an Everolimus based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients One Year After Conversion

Presenter: Klemens Budde, Berlin, Germany

Influence of CYP3A5 and MDR1 polymorphism on the pharmacokinetics of tacrolimus in response to metabolic inhibition by diltiazem.

Presenter: Longshan LIU, Guangzhou, People's Republic of China

- Influence of CYP3A5 and MDR1 polymorphism on the pharmacokinetics of tacrolimus in response to metabolic inhibition by diltiazem.

Presenter: Longshan LIU, Guangzhou, People's Republic of China

Diltiazem may facilitate tacrolimus dose adjustment in the early stage after kidney transplantation in CYP3A5 expressers, a preliminary prospective study.

Presenter: Longshan LIU, Guangzhou, People's Republic of China

- Diltiazem may facilitate tacrolimus dose adjustment in the early stage after kidney transplantation in CYP3A5 expressers, a preliminary prospective study.

Presenter: Longshan LIU, Guangzhou, People's Republic of China

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi